108 related articles for article (PubMed ID: 11701402)
1. Expression of stromelysin 3 in basal cell carcinomas.
Cribier B; Noacco G; Peltre B; Grosshans E
Eur J Dermatol; 2001; 11(6):530-3. PubMed ID: 11701402
[TBL] [Abstract][Full Text] [Related]
2. Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma.
Wagner SN; Ruhri C; Kunth K; Holecek BU; Goos M; Höfler H; Atkinson MJ
Diagn Mol Pathol; 1992 Sep; 1(3):200-5. PubMed ID: 1342967
[TBL] [Abstract][Full Text] [Related]
3. Stromelysin-3 protein expression in invasive breast cancer: relation to proliferation, cell survival and patients' outcome.
Nakopoulou L; Panayotopoulou EG; Giannopoulou I; Alexandrou P; Katsarou S; Athanassiadou P; Keramopoulos A
Mod Pathol; 2002 Nov; 15(11):1154-61. PubMed ID: 12429794
[TBL] [Abstract][Full Text] [Related]
4. Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Bolon I; Devouassoux M; Robert C; Moro D; Brambilla C; Brambilla E
Am J Pathol; 1997 May; 150(5):1619-29. PubMed ID: 9137088
[TBL] [Abstract][Full Text] [Related]
5. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma.
Kawasaki K; Kawakami T; Watabe H; Itoh F; Mizoguchi M; Soma Y
Br J Dermatol; 2007 Apr; 156(4):613-9. PubMed ID: 17493064
[TBL] [Abstract][Full Text] [Related]
7. Stromelysin-3 gene expression in human cancer: an overview.
Rouyer N; Wolf C; Chenard MP; Rio MC; Chambon P; Bellocq JP; Basset P
Invasion Metastasis; 1994-1995; 14(1-6):269-75. PubMed ID: 7657519
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of protein kinase C-alpha and -beta isozymes by stromal dendritic cells in basal and squamous cell carcinoma.
Reynolds NJ; Todd C; Angus B
Br J Dermatol; 1997 May; 136(5):666-73. PubMed ID: 9205496
[TBL] [Abstract][Full Text] [Related]
9. Expression of stromelysin 3 in keratoarcanthoma and squamous cell carcinoma.
Asch PH; Basset P; Roos M; Grosshans E; Bellocq JP; Cribier B
Am J Dermatopathol; 1999 Apr; 21(2):146-50. PubMed ID: 10218674
[TBL] [Abstract][Full Text] [Related]
10. Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans.
Cribier B; Noacco G; Peltre B; Grosshans E
J Am Acad Dermatol; 2002 Mar; 46(3):408-13. PubMed ID: 11862177
[TBL] [Abstract][Full Text] [Related]
11. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies.
Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N
Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330
[TBL] [Abstract][Full Text] [Related]
12. Expression of the peripheral benzodiazepine receptor is decreased in skin cancers in comparison with normal skin.
Morgan J; Oseroff AR; Cheney RT
Br J Dermatol; 2004 Oct; 151(4):846-56. PubMed ID: 15491426
[TBL] [Abstract][Full Text] [Related]
13. Correlations among neural cell adhesion molecule, nerve growth factor, and its receptors, TrkA, TrkB, TrkC, and p75, in perineural invasion by basal cell and cutaneous squamous cell carcinomas.
Chen-Tsai CP; Colome-Grimmer M; Wagner RF
Dermatol Surg; 2004 Jul; 30(7):1009-16. PubMed ID: 15209791
[TBL] [Abstract][Full Text] [Related]
14. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
[TBL] [Abstract][Full Text] [Related]
15. Expression of stromelysin-3 in medullary carcinoma of the breast.
Holm R; Flørenes VA; Erikstein B; Nesland JM
Anticancer Res; 1997; 17(5B):3725-7. PubMed ID: 9427769
[TBL] [Abstract][Full Text] [Related]
16. Maspin expression in normal skin and usual cutaneous carcinomas.
Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
Virchows Arch; 2002 Dec; 441(6):551-8. PubMed ID: 12461611
[TBL] [Abstract][Full Text] [Related]
17. Expression of individual lamins in basal cell carcinomas of the skin.
Venables RS; McLean S; Luny D; Moteleb E; Morley S; Quinlan RA; Lane EB; Hutchison CJ
Br J Cancer; 2001 Feb; 84(4):512-9. PubMed ID: 11207047
[TBL] [Abstract][Full Text] [Related]
18. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
[TBL] [Abstract][Full Text] [Related]
19. Incomplete primary excision of cutaneous basal and squamous cell carcinomas in the Bay of Plenty.
Talbot S; Hitchcock B
N Z Med J; 2004 Apr; 117(1192):U848. PubMed ID: 15107870
[TBL] [Abstract][Full Text] [Related]
20. P16 is overexpressed in cutaneous carcinomas located on sun-exposed areas.
Conscience I; Jovenin N; Coissard C; Lorenzato M; Durlach A; Grange F; Birembaut P; Clavel C; Bernard P
Eur J Dermatol; 2006; 16(5):518-22. PubMed ID: 17101472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]